Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study.
Kalyani MaratheJoyce M C TengScott GuenthnerChristopher G BunickSteven KempersKimmie EadsLeslie Castelo-SoccioAlan M MendelsohnJessica RaizDédée F MurrellPublished in: Dermatology and therapy (2023)
NCT04154293.